tyrosine has been researched along with Hyperlipoproteinemia Type II in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, TJ; Calkin, AC; Cooper, ME; de Haan, JB; Giunti, S; Jandeleit-Dahm, KA; Kola, I; Lewis, P; Pete, J; Stefanovic, N; Thallas-Bonke, V | 1 |
Allende, H; Boix-Ochoa, J; Infante, D; Margarit, C; Martínez Ibáñez, V; Sanchís, L; Tormo, R | 1 |
Anderson, RG; Brown, MS; Davis, CG; Goldstein, JL; Lehrman, MA; Russell, DW | 1 |
3 other study(ies) available for tyrosine and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Fibrosis; Gene Expression Regulation; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hyperlipoproteinemia Type II; Immediate-Early Proteins; Inflammation; Intercellular Signaling Peptides and Proteins; Isoenzymes; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Oxidation-Reduction; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sinus of Valsalva; Streptozocin; Superoxide Dismutase; Tyrosine; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2007 |
[New perspectives in liver-based metabolic errors: liver transplantation].
Topics: alpha 1-Antitrypsin Deficiency; Amino Acid Metabolism, Inborn Errors; Child; Female; Glycogen Storage Disease Type II; Humans; Hyperlipoproteinemia Type II; Infant, Newborn; Liver; Liver Cirrhosis; Liver Transplantation; Male; Metabolism, Inborn Errors; Tyrosine | 1989 |
The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors.
Topics: Alleles; Amino Acid Sequence; Base Sequence; Cell Compartmentation; Cloning, Molecular; Cysteine; Endocytosis; Humans; Hyperlipoproteinemia Type II; Mutation; Receptors, LDL; Structure-Activity Relationship; Transfection; Tyrosine | 1986 |